These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25952057)

  • 1. In vitro studies in a myelogenous leukemia cell line suggest an organized binding of geranylgeranyl diphosphate synthase inhibitors.
    Reilly JE; Zhou X; Tong H; Kuder CH; Wiemer DF; Hohl RJ
    Biochem Pharmacol; 2015 Jul; 96(2):83-92. PubMed ID: 25952057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
    Wiemer AJ; Yu JS; Lamb KM; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2008 Jan; 16(1):390-9. PubMed ID: 17905588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amides as bioisosteres of triazole-based geranylgeranyl diphosphate synthase inhibitors.
    Goetz DB; Varney ML; Wiemer DF; Holstein SA
    Bioorg Med Chem; 2020 Aug; 28(16):115604. PubMed ID: 32690260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.
    Wiemer AJ; Tong H; Swanson KM; Hohl RJ
    Biochem Biophys Res Commun; 2007 Feb; 353(4):921-5. PubMed ID: 17208200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate.
    Wasko BM; Dudakovic A; Hohl RJ
    J Pharmacol Exp Ther; 2011 May; 337(2):540-6. PubMed ID: 21335425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors.
    Haney SL; Wills VS; Wiemer DF; Holstein SA
    Molecules; 2017 May; 22(6):. PubMed ID: 28555000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution.
    Haney SL; Chhonker YS; Varney ML; Talmon G; Smith LM; Murry DJ; Holstein SA
    J Pharmacol Exp Ther; 2019 Nov; 371(2):327-338. PubMed ID: 31420526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation.
    Wiemer AJ; Yu JS; Shull LW; Barney RJ; Wasko BM; Lamb KM; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2008 Apr; 16(7):3652-60. PubMed ID: 18308574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Methylation enhances the potency of isoprenoid triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
    Matthiesen RA; Varney ML; Xu PC; Rier AS; Wiemer DF; Holstein SA
    Bioorg Med Chem; 2018 Jan; 26(2):376-385. PubMed ID: 29248353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olefin Isomers of a Triazole Bisphosphonate Synergistically Inhibit Geranylgeranyl Diphosphate Synthase.
    Allen C; Kortagere S; Tong H; Matthiesen RA; Metzger JI; Wiemer DF; Holstein SA
    Mol Pharmacol; 2017 Mar; 91(3):229-236. PubMed ID: 28057800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of isoprenoid bisphosphonates.
    Shull LW; Wiemer AJ; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2006 Jun; 14(12):4130-6. PubMed ID: 16517172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.
    Wills VS; Metzger JI; Allen C; Varney ML; Wiemer DF; Holstein SA
    Bioorg Med Chem; 2017 Apr; 25(8):2437-2444. PubMed ID: 28302510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of α-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
    Fairweather AER; Goetz DB; Schroeder CM; Bhuiyan NH; Varney ML; Wiemer DF; Holstein SA
    Bioorg Med Chem; 2021 Aug; 44():116307. PubMed ID: 34298413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ω-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitors.
    Bhuiyan NH; Varney ML; Bhattacharya DS; Payne WM; Mohs AM; Holstein SA; Wiemer DF
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126633. PubMed ID: 31474482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of a series of aromatic bisphosphonates.
    Barney RJ; Wasko BM; Dudakovic A; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2010 Oct; 18(20):7212-20. PubMed ID: 20832326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Amino bisphosphonate triazoles serve as GGDPS inhibitors.
    Gehrke NR; Feng D; Ayub Ali M; Maalouf MA; Holstein SA; Wiemer DF
    Bioorg Med Chem Lett; 2024 Apr; 102():129659. PubMed ID: 38373465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation.
    Agabiti SS; Li J; Wiemer AJ
    Cell Death Dis; 2017 Mar; 8(3):e2678. PubMed ID: 28300835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes.
    Dudakovic A; Wiemer AJ; Lamb KM; Vonnahme LA; Dietz SE; Hohl RJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1028-36. PubMed ID: 18083912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geranylgeranyl diphosphate depletion inhibits breast cancer cell migration.
    Dudakovic A; Tong H; Hohl RJ
    Invest New Drugs; 2011 Oct; 29(5):912-20. PubMed ID: 20480384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target.
    Muehlebach ME; Holstein SA
    Clin Transl Med; 2023 Jan; 13(1):e1167. PubMed ID: 36650113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.